2037 |
Evidence-based Pharmacotherapy for ACS Patients: The Forest and the Trees |
Gregg W. Stone |
May. 18. 12 |
2036 |
P2Y12 Receptor Blockers: Which Drug (Clopidogrel, Prasugrel, and Ticagrelor) and for Whom? |
Cheol Whan Lee |
May. 18. 12 |
2035 |
Reduction of Thrombus: Routine vs. Selective Aspiration |
Gregg W. Stone |
May. 18. 12 |
2034 |
Reduction of Thrombus: Local vs. Systemic GPI Infusion |
Mun Kyung Hong |
May. 18. 12 |
2033 |
Update of Dedicated Bifurcation Stent |
Martin Bert Leon |
May. 18. 12 |
2032 |
Current Status of CROSS and PERFECT Study |
Young-Hak Kim |
May. 18. 12 |
2031 |
Long-term Outcomes of Non-LM Bifurcation Studies |
Yves R. Louvard |
May. 18. 12 |
2030 |
My Top 10 Rules in Non-LM Bifurcation Stenting |
Antonio Colombo |
May. 18. 12 |
2029 |
Why FFR and Why Not FFR in Bifurcation Lesions |
Bon-Kwon Koo |
May. 18. 12 |
2028 |
Plaque Shift vs. Carina Shift: Identification and Clinical Impact |
Soo-Jin Kang |
May. 18. 12 |